Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.

  title={Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.},
  author={Rakesh K. Jain and Alain Katic},
  journal={The primary care companion for CNS disorders},
  volume={18 4}
  • R. Jain, A. Katic
  • Published 18 August 2016
  • Medicine
  • The primary care companion for CNS disorders
OBJECTIVE To review currently available formulations and emphasize unmet needs in the pharmacologic management of attention-deficit/hyperactivity disorder (ADHD). DATA SOURCES Publications and clinical trials were identified through PubMed and, respectively. A Web-based search identified prescribing information for approved agents for treating ADHD, along with relevant guidelines and diagnostic criteria. STUDY SELECTION The following search terms were used: (1) ADHD or… 
Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners.
Practical aspects of pharmacological treatment of ADHD in children and adolescents are reviewed, including use of stimulant and non-stimulant medications.
Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study
Evaluating the efficacy and safety of SHP465 mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder (ADHD) found that the percentage of participants categorized as improved on Clinical Global Impressions-Improvement was higher with both SHP 465 MAS doses than with placebo (both nominal p < 0.001).
Treatment Resistance in Attention-Deficit/Hyperactivity Disorder
In this chapter, the authors discuss both established and novel pharmacological treatment and neuromodulation in treatment-resistant ADHD.
Children's Attention-Deficit/Hyperactivity Disorder Symptoms Predict Lower Diet Quality but Not Vice Versa: Results from Bidirectional Analyses in a Population-Based Cohort.
This study suggests that children with more ADHD symptoms may be at higher risk of an unhealthy diet but that overall diet quality does not affect ADHD risk.
Diagnosis and treatment of ADHD in children vs adults: What nurses should know
  • L. Leahy
  • Medicine, Psychology
    Archives of psychiatric nursing
  • 2018
Population Pharmacokinetic-Pharmacodynamic Modeling of a Novel Methylphenidate Extended-Release Orally Disintegrating Tablet in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder
A population pharmacokinetic (PK)/pharmacodynamic (PD) model is developed to describe MPH XR-ODT PD-response data in a classroom study and use the model to simulate PD responses for a range of body weights and doses to help facilitate the dose-titration process.
A randomized, double-blind study of SHP465 mixed amphetamine salts extended-release in adults with ADHD using a simulated adult workplace design
SHP465MAS (combined 50/75 mg) significantly improved PERMP total score versus placebo, with superiority observed from 2 to 16 h postdose, and the tolerability profile of SHP465 MAS was similar to previous reports of SHp465 MAS in adults with ADHD.
Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environment
SHP465 MAS (25 mg) was superior to placebo on PERMP total score, with treatment differences observed from 4 to 16 hours postdose; nominal treatment differences on the ADHD-SRS, but not the Co-ADHD-RS TSRS, were also observed.
Effects of medications on ventricular repolarization in children with attention deficit hyperactivity disorder
Attention deficit hyperactivity disorder (ADHD) is a multifactorial neurodevelopmental disorder that manifests during childhood. Methylphenidate (MPH), which is a psychostimulant drug, has been often